Skip to main content
. 2021 Nov 2;9(1):e1097. doi: 10.1212/NXI.0000000000001097

Table 2.

Outcome Measures Comparing Maraviroc-Treated Patients and Controls

graphic file with name NEURIMMINFL2021039209T2.jpg